MSPR · MSP Recovery, Inc.

Represents shares of Class A Common Stock issuable in respect of an equal number of Class B units (the "LLC Units") of Lionheart II Holdings,LLC, a wholly owned subsidiary of the Issuer ("Opco"), and shares of Class V common stock, par value $0.0001 per share ("Class V Common Stock," and together with an LLC Unit, an "Up-C Unit"), subject to the terms of the First Amended and Restated Limited Liability CompanyAgreement of Lionheart II Holdings, LLC (the "LLC Agreement"). Effective December 13, 2024, pursuant to a marital settlement agreement, Mayra C. Ruiz acquired from John H. Ruiz: (i) Ruiz Group Holdings Limited, LLC, which holds 692,123 Up-C Units; and (ii) 320,000 Up-C Units held by Jocral Family LLLP.

Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

Represents Up-C Units held as follows: (a) 692,123 Up-C Units by Ruiz Group Holdings Limited, LLC; and (b) 320,000 Up-C Units held by Mayra C. Ruiz, individually.

Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in Ruiz Group Holdings Limited, LLC to his ex-wife, Mayra Ruiz, which beneficially owned 16,000 shares of Class A Common Stock.

Represents: (a) 40,000 shares of Class A Common Stock held by Jocral Family LLLP; and (b) 71,657 shares of Class A Common Stock held John H. Ruiz, individually.

Represents LLC units ("LLC Units") of Lionheart II Holdings, LLC ("Opco"), which are ach paired with one share of Class V Common Stock, par value $0.0001 per share, of the Issuer ("Class V Common Stock"). Each share of Class V Common Stock has the same voting rights as a share of Class A common stock, par value $0.0001 per share, of the Issuer ("Class A Common Stock"), but no economic rights. Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in: (i) Ruiz Group Holdings Limited, LLC, which beneficially owned 692,123 Up-C Units, and (ii) 320,000 Up-C Units held by Jocral Family LLLP.

Pursuant to the first amended and restated limited liability company agreement of Opco, dated as of May 23, 2022 (the "LLC Agreement"), the LLC Units have no expiration date and each LLC Unit, together with a share of Class V Common Stock, is exchangeable for one share of Class A Common Stock.

Represents shares of Class A Common Stock issuable in respect of an equal number of Class B units (the "LLC Units") of Lionheart II Holdings, LLC, a wholly owned subsidiary of the Issuer ("Opco"), and shares of Class V common stock, par value $0.0001 per share ("Class V Common Stock," and together with an LLC Unit, an "Up-C Unit"), subject to the terms of the First Amended and Restated Limited Liability Company Agreement of Lionheart II Holdings, LLC (the "LLC Agreement"), held as follows: (a) 463,096 by Series MRCS, a series of MDA, Series LLC ("Series MRCS") (including 80,271 held on behalf of Jocral Holdings LLC); and (b) 1,859,435 by Jocral Family LLLP.

Effective December 13, 2024, pursuant to a marital settlement agreement, John H. Ruiz transferred all of his interest in Ruiz Group Holdings Limited, LLC to his ex-wife, Mayra C. Ruiz, which beneficially owned 16,000 shares of Class A Common Stock.

Includes 16,000 shares of Class A Common Stock held by Ruiz Group Holdings Limited, LLC.

Represents 16,000 shares of Class A Common Stock held by Ruiz Group Holdings Limited, LLC.

This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.1035 to $0.1638. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.10 to $0.1185. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.097 to $0.1055. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.092 to $0.1129. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.098 to $0.1352. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $0.1195 to $0.1287. The price reported above reflects the weighted average sale price of trades occurring within that price range. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.72 to $1.035. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6642 to $0.6789. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.683 to $0.701. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.7344. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7222 to $0.735. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.74 to $0.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.771. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.775. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.795. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.78 to $0.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.83 to $0.8675. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.88 to $0.9395. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.93 to $0.9902. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.95 to $1.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.93 to $1.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.98 to $1.11. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The securities identified in Box 4 were purchased pursuant to a Stock Transfer Agreement dated March 4, 2024 by and between the Reporting Person and Virage Capital Managment LP ("Seller"). Payment by Reporting Person for the above-reference securities is due to Seller no later than May 1, 2024.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $1.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.862. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.825. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8043 to $0.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8019 to $0.8288. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.845. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.855. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.835. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.84. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.8099. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.